Literature DB >> 19336372

Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants.

Namasivayam Ambalavanan1, Waldemar A Carlo, Carl T D'Angio, Scott A McDonald, Abhik Das, Diana Schendel, Poul Thorsen, Rosemary D Higgins.   

Abstract

OBJECTIVE: The goal was to develop multivariate logistic regression models for the outcome of bronchopulmonary dysplasia and/or death at postmenstrual age of 36 weeks by using clinical and cytokine data from the first 28 days.
METHODS: For 1067 extremely low birth weight infants in the Neonatal Research Network of the National Institute of Child Health and Human Development, levels of 25 cytokines were measured in blood collected within 4 hours after birth and on days 3, 7, 14, and 21. Stepwise regression analyses using peak levels of the 25 cytokines and 15 clinical variables identified variables associated with bronchopulmonary dysplasia/death. Multivariate logistic regression analysis was performed for bronchopulmonary dysplasia/death by using variables selected through stepwise regression. Similar analyses were performed by using average cytokine values from days 0 to 21, days 0 to 3, and days 14 to 21.
RESULTS: Of 1062 infants with available data, 606 infants developed bronchopulmonary dysplasia or died. On the basis of results from all models combined, bronchopulmonary dysplasia/death was associated with higher concentrations of interleukin 1beta, 6, 8, and 10 and interferon gamma and lower concentrations of interleukin 17, regulated on activation, normal T cell expressed and secreted, and tumor necrosis factor beta. Compared with models with only clinical variables, the addition of cytokine data improved predictive ability by a statistically significant but clinically modest magnitude.
CONCLUSIONS: The overall cytokine pattern suggests that bronchopulmonary dysplasia/death may be associated with impairment in the transition from the innate immune response mediated by neutrophils to the adaptive immune response mediated by T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336372      PMCID: PMC2903210          DOI: 10.1542/peds.2008-0526

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  38 in total

Review 1.  Cytokines in innate host defense in the lung.

Authors:  Robert M Strieter; John A Belperio; Michael P Keane
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 2.  Bronchopulmonary dysplasia: new insights.

Authors:  Namasivayam Ambalavanan; Waldemar A Carlo
Journal:  Clin Perinatol       Date:  2004-09       Impact factor: 3.430

Review 3.  IL-17A-producing neutrophil-regulatory Tn lymphocytes.

Authors:  Klaus Ley; Emily Smith; Matthew A Stark
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Signalling pathways of the TNF superfamily: a double-edged sword.

Authors:  Bharat B Aggarwal
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

5.  Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression.

Authors:  H Liu; D Chao; E E Nakayama; H Taguchi; M Goto; X Xin; J K Takamatsu; H Saito; Y Ishikawa; T Akaza; T Juji; Y Takebe; T Ohishi; K Fukutake; Y Maruyama; S Yashiki; S Sonoda; T Nakamura; Y Nagai; A Iwamoto; T Shioda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 6.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 7.  Transcriptional regulation of RANTES expression in T lymphocytes.

Authors:  A Song; T Nikolcheva; A M Krensky
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

8.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

Authors:  M Jakkula; T D Le Cras; S Gebb; K P Hirth; R M Tuder; N F Voelkel; S H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-09       Impact factor: 5.464

9.  Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults.

Authors:  Antonella Gasparoni; Laura Ciardelli; Antonia Avanzini; Anna Maria Castellazzi; Roberta Carini; Giorgio Rondini; Gaetano Chirico
Journal:  Biol Neonate       Date:  2003

10.  Interferon-gamma: a key contributor to hyperoxia-induced lung injury in mice.

Authors:  Mitsuhiro Yamada; Hiroshi Kubo; Seiichi Kobayashi; Kota Ishizawa; Hidetada Sasaki
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-07-16       Impact factor: 5.464

View more
  108 in total

1.  Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia.

Authors:  Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

2.  Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy.

Authors:  C Michael Cotten; Amy P Murtha; Ronald N Goldberg; Chad A Grotegut; P Brian Smith; Ricki F Goldstein; Kimberley A Fisher; Kathryn E Gustafson; Barbara Waters-Pick; Geeta K Swamy; Benjamin Rattray; Siddhartha Tan; Joanne Kurtzberg
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

3.  Efficacy of Leukadherin-1 in the Prevention of Hyperoxia-Induced Lung Injury in Neonatal Rats.

Authors:  Jawahar Jagarapu; Jelte Kelchtermans; Min Rong; Shaoyi Chen; Dorothy Hehre; Stefanie Hummler; Mohd Hafeez Faridi; Vineet Gupta; Shu Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

4.  Human mesenchymal stem cells attenuate hyperoxia-induced lung injury through inhibition of the renin-angiotensin system in newborn rats.

Authors:  Chung-Ming Chen; Hsiu-Chu Chou
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

Review 5.  The Ontogeny of Skin.

Authors:  Marty Visscher; Vivek Narendran
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

6.  Association of antenatal steroid use with cord blood immune biomarkers in preterm births.

Authors:  Praveen Kumar; Scott A Venners; Lingling Fu; Colleen Pearson; Katherin Ortiz; Xiaobin Wang
Journal:  Early Hum Dev       Date:  2011-05-14       Impact factor: 2.079

7.  Perinatal factors in neonatal and pediatric lung diseases.

Authors:  Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Expert Rev Respir Med       Date:  2013-10-03       Impact factor: 3.772

8.  VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice.

Authors:  Masheika L James; A Catharine Ross; Teodora Nicola; Chad Steele; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-12       Impact factor: 5.464

9.  The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia.

Authors:  Jie Liao; Vishal S Kapadia; L Steven Brown; Naeun Cheong; Christopher Longoria; Dan Mija; Mrithyunjay Ramgopal; Julie Mirpuri; Donald C McCurnin; Rashmin C Savani
Journal:  Nat Commun       Date:  2015-11-27       Impact factor: 14.919

10.  Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.

Authors:  Gareth R Willis; Angeles Fernandez-Gonzalez; Jamie Anastas; Sally H Vitali; Xianlan Liu; Maria Ericsson; April Kwong; S Alex Mitsialis; Stella Kourembanas
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.